Literature DB >> 16082008

Detection of five novel CTX-M-type extended spectrum beta-lactamases with one to three CTX-M-14 point mutations in isolates from Hefei, Anhui province, China.

Hui Li, Jia Bin Li.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16082008      PMCID： PMC1233894          DOI： 10.1128/JCM.43.8.4301-4302.2005

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


× No keyword cloud information.
  9 in total

Review 1.  Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat.

Authors:  P A Bradford
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

Review 2.  Growing group of extended-spectrum beta-lactamases: the CTX-M enzymes.

Authors:  R Bonnet
Journal:  Antimicrob Agents Chemother       Date:  2004-01       Impact factor: 5.191

3.  Identification and broad dissemination of the CTX-M-14 beta-lactamase in different Escherichia coli strains in the northwest area of Spain.

Authors:  German Bou; Monica Cartelle; Maria Tomas; Delia Canle; Francisca Molina; Rita Moure; Jose Maria Eiros; Antonio Guerrero
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

4.  A237T as a modulating mutation in naturally occurring extended-spectrum TEM-type beta-lactamases.

Authors:  J Blázquez; M C Negri; M I Morosini; J M Gómez-Gómez; F Baquero
Journal:  Antimicrob Agents Chemother       Date:  1998-05       Impact factor: 5.191

5.  Novel cefotaximase (CTX-M-16) with increased catalytic efficiency due to substitution Asp-240-->Gly.

Authors:  R Bonnet; C Dutour; J L Sampaio; C Chanal; D Sirot; R Labia; C De Champs; J Sirot
Journal:  Antimicrob Agents Chemother       Date:  2001-08       Impact factor: 5.191

6.  Prevalence and analysis of risk factors for infections caused by resistant Escherichia coli strains in Anhui, China.

Authors:  J B Li; Y S Yu; Y L Ma; W L Zhou; X Z Yu
Journal:  Infection       Date:  2001-08       Impact factor: 3.553

7.  CTX-M-14, a plasmid-mediated CTX-M type extended-spectrum beta-lactamase isolated from Escherichia coli.

Authors:  L Ma; Yoshikazu Ishii; Feng-Yee Chang; Keizo Yamaguchi; Monto Ho; L K Siu
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

8.  Predominance and genetic diversity of community- and hospital-acquired CTX-M extended-spectrum beta-lactamases in York, UK.

Authors:  C J Munday; G M Whitehead; N J Todd; M Campbell; P M Hawkey
Journal:  J Antimicrob Chemother       Date:  2004-08-04       Impact factor: 5.790

9.  Dissemination of CTX-M type beta-lactamases in Enterobacteriaceae isolates in the People's Republic of China.

Authors:  C J Munday; J Xiong; C Li; D Shen; P M Hawkey
Journal:  Int J Antimicrob Agents       Date:  2004-02       Impact factor: 5.283
  9 in total
  3 in total

1.  Beta-lactamase nomenclature.

Authors:  George A Jacoby; Karen Bush
Journal:  J Clin Microbiol       Date:  2005-12       Impact factor: 5.948

2.  Novel chimeric beta-lactamase CTX-M-64, a hybrid of CTX-M-15-like and CTX-M-14 beta-lactamases, found in a Shigella sonnei strain resistant to various oxyimino-cephalosporins, including ceftazidime.

Authors:  Yukiko Nagano; Noriyuki Nagano; Jun-ichi Wachino; Keiko Ishikawa; Yoshichika Arakawa
Journal:  Antimicrob Agents Chemother       Date:  2008-10-27       Impact factor: 5.191

3.  Prevalence of aac(6')-Ib-cr plasmid-mediated and chromosome-encoded fluoroquinolone resistance in Enterobacteriaceae in Italy.

Authors:  Ilaria Frasson; Antonietta Cavallaro; Cristina Bergo; Sara N Richter; Giorgio Palù
Journal:  Gut Pathog       Date:  2011-08-09       Impact factor: 4.181
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.